Valion Bio, Inc. (VBIO) Operating cash flow 2021–2025
Valion Bio, Inc. (VBIO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$7.0MFY2025 · since FY2021: -$5.6M → -$7.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.0M | -22.3% |
| FY2024 | -$5.7M | +32.7% |
| FY2023 | -$8.5M | +4.6% |
| FY2022 | -$8.9M | -58.9% |
| FY2021 | -$5.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice